Petros Pharmaceuticals
PTPI
#10254
Rank
A$6.12 M
Marketcap
$0.61
Share price
3.32%
Change (1 day)
-68.95%
Change (1 year)

Revenue for Petros Pharmaceuticals (PTPI)

Revenue in 2024 (TTM): A$5.99 Million

According to Petros Pharmaceuticals's latest financial reports the company's current revenue (TTM ) is A$6.54 Million. In 2023 the company made a revenue of A$8.54 Million a decrease over the revenue in the year 2022 that were of A$8.8 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Petros Pharmaceuticals from 2020 to 2024

202120222023$6M$8M$10M$12M$14Mcompaniesmarketcap.com

Annual revenue

Year Revenue Change
2024 (TTM) A$5.99 M-29.8%
2023 A$8.54 M-2.95%
2022 A$8.8 M-18.28%
2021 A$10.77 M-13.33%
2020 A$12.43 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
A$0.23 B 3,483.79%๐Ÿ‡บ๐Ÿ‡ธ USA
N/AN/A Bahamas